Eugene Holuka
Board Member
Citius Oncology, Inc. (CTOR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eugene Holuka
Eugene Holuka is recorded as Board Member at Citius Oncology, Inc. (CTOR). Citius Oncology, Inc. reported in an 8-K filed August 16, 2024 that Eugene Holuka was appointed Class II Director, effective August 12, 2024.
“Each of Mr. Myron Holubiak (Class I), Mr. Joel Mayersohn (Class I), Dr. Eugene Holuka (Class II), Mr. Robert Smith (Class II), Ms. Carol Webb (Class II), Mr. Suren Dutia (Class III), Mr. Leonard Mazur (Class III and Chairman) and Mr. Dennis McGrath (Class III) were elected to serve as directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Citius Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Leonard Mazur CEO, Chairman, Board Member
- Myron Holubiak Chairman, Board Member
- Jaime Bartushak CFO
- Carol Webb Board Member
- Dennis M. McGrath Board Member
- Dennis McGrath Board Member
- Dr. Eugene Holuka Board Member
- Joel Mayersohn Board Member
- Jonathan Peri Board Member
- Robert Smith Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.